Mugen Ujiie

1.9k total citations · 1 hit paper
51 papers, 640 citations indexed

About

Mugen Ujiie is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mugen Ujiie has authored 51 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 19 papers in Epidemiology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mugen Ujiie's work include SARS-CoV-2 and COVID-19 Research (12 papers), Mosquito-borne diseases and control (10 papers) and Viral Infections and Vectors (9 papers). Mugen Ujiie is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Mosquito-borne diseases and control (10 papers) and Viral Infections and Vectors (9 papers). Mugen Ujiie collaborates with scholars based in Japan, United States and Switzerland. Mugen Ujiie's co-authors include Shinya Tsuzuki, Norio Ohmagari, Noriko Iwamoto, Takato Nakamoto, Satoshi Kutsuna, Tetsuya Suzuki, Shuzo Kanagawa, Nozomi Takeshita, Yasuyuki Kato and Hidetoshi Nomoto and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Mugen Ujiie

42 papers receiving 624 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan

2021 167 citations Mugen Ujiie, Shinya Tsuzuki et al. Emerging infectious diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mugen Ujiie Japan	13	328	233	139	90	75	51	640
Simon P. Jochems Netherlands	14	170 0.5×	231 1.0×	50 0.4×	67 0.7×	35 0.5×	37	640
Saied Ghorbani Iran	13	486 1.5×	178 0.8×	106 0.8×	60 0.7×	41 0.5×	49	1.0k
Praveen Dhankhar United States	10	223 0.7×	433 1.9×	113 0.8×	83 0.9×	30 0.4×	18	859
Carmen Sofia Arriola United States	13	205 0.6×	403 1.7×	93 0.7×	87 1.0×	88 1.2×	29	627
Tommy Rampling United Kingdom	11	230 0.7×	185 0.8×	163 1.2×	50 0.6×	75 1.0×	28	706
Susanne H. Hodgson United Kingdom	14	423 1.3×	93 0.4×	190 1.4×	102 1.1×	51 0.7×	24	864
Katherine A. Twohig United Kingdom	8	555 1.7×	80 0.3×	192 1.4×	192 2.1×	40 0.5×	17	855
Lindsay Czajkowski United States	10	322 1.0×	605 2.6×	56 0.4×	78 0.9×	54 0.7×	15	850
Alexander Roberto Precioso Brazil	16	216 0.7×	192 0.8×	146 1.1×	27 0.3×	67 0.9×	50	648
Karen Donceras Nadua Singapore	11	532 1.6×	144 0.6×	174 1.3×	102 1.1×	58 0.8×	26	756

Countries citing papers authored by Mugen Ujiie

Since Specialization

Citations

This map shows the geographic impact of Mugen Ujiie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mugen Ujiie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mugen Ujiie more than expected).

Fields of papers citing papers by Mugen Ujiie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mugen Ujiie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mugen Ujiie. The network helps show where Mugen Ujiie may publish in the future.

Co-authorship network of co-authors of Mugen Ujiie

This figure shows the co-authorship network connecting the top 25 collaborators of Mugen Ujiie. A scholar is included among the top collaborators of Mugen Ujiie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mugen Ujiie. Mugen Ujiie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamamoto, Shohei, Tetsuya Mizoue, Mugen Ujiie, et al.. (2025). Low Levels of Postvaccination Hemagglutination Inhibition Antibodies and Their Correlation With Influenza Protection Among Healthcare Workers During the 2024–2025 A/H1N1 Outbreak in Japan. The Journal of Infectious Diseases. 232(3). 727–734. 1 indexed citations

Ujiie, Mugen. (2025). Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan. Emerging infectious diseases. 31(4). 847–849. 5 indexed citations

Terada-Hirashima, Junko, Yukari Uemura, Noriko Tomita, et al.. (2023). Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study. JMIR Research Protocols. 12. e46955–e46955. 4 indexed citations

Ohashi, Yasukata, Junichi Masuda, Katsuji Teruya, et al.. (2023). Introducing Ritonavir-Boosted Nirmatrelvir (Paxlovid) at the National Center for Global Health and Medicine: Surveys Following its Introduction. Kansenshogaku zasshi. 97(4). 125–135.

Inoue, Yosuke, Yunfei Li, Shohei Yamamoto, et al.. (2023). The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine: An observational study. Vaccine. 41(49). 7317–7321.

Ujiie, Mugen, Takato Nakamoto, Noriko Iwamoto, & Shinya Tsuzuki. (2023). Large-scale resurgence of herpangina in Japan, following the easing of COVID-19 measures. IJID Regions. 10. 15–17. 3 indexed citations

Yamamoto, Shohei, Ami Fukunaga, Akihito Tanaka, et al.. (2022). Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine. 40(13). 1924–1927. 20 indexed citations

Khor, Seik‐Soon, Yosuke Omae, Junko S. Takeuchi, et al.. (2022). An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine. Vaccines. 10(4). 563–563. 9 indexed citations

Tsuzuki, Shinya, Sho Saito, Shin-ichiro Hattori, et al.. (2022). Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan. Journal of Infection and Chemotherapy. 28(9). 1340–1343. 1 indexed citations

10.

Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2022). Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection. International Journal of Infectious Diseases. 119. 18–20.

11.

Ishikane, Masahiro, Souichi Yamada, Noriko Iwamoto, et al.. (2021). Varicella pneumonia in an immunocompetent, unvaccinated man: A case report. IJID Regions. 2. 60–62. 3 indexed citations

12.

Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2021). Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. Journal of Infection and Chemotherapy. 27(7). 1063–1067. 7 indexed citations

13.

Ide, Satoshi, Satoshi Kutsuna, Gen Yamada, et al.. (2021). Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report. Journal of Infection and Chemotherapy. 27(11). 1658–1661. 1 indexed citations

14.

Yamamoto, Kei, Michiyo Suzuki, Mugen Ujiie, Shuzo Kanagawa, & Norio Ohmagari. (2021). Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan. PLoS ONE. 16(10). e0258357–e0258357.

15.

Ishikane, Masahiro, et al.. (2021). A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient. International Journal of Infectious Diseases. 113. 55–57. 15 indexed citations

16.

Nomoto, Hidetoshi, Satoshi Kutsuna, Mugen Ujiie, et al.. (2021). Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan. Emerging infectious diseases. 27(4). 95 indexed citations

17.

Ujiie, Mugen, Taito Kitano, & Shinya Tsuzuki. (2021). Changing trends in HPV vaccination in Japan. Human Vaccines & Immunotherapeutics. 18(1). 1–3. 20 indexed citations

18.

Ujiie, Mugen, Norio Ohmagari, & Hajime Inoue. (2020). Testing for COVID-19 at travel clinics in Japan. Journal of Travel Medicine. 27(5). 2 indexed citations

19.

Yamamoto, Kei, Mugen Ujiie, Akira Noguchi, et al.. (2019). Rabies post-exposure prophylactic vaccination for returning travelers to Japan. Journal of Infection and Chemotherapy. 25(12). 931–935. 3 indexed citations

20.

Mizuno, Yasutaka, Yasuyuki Kato, Nozomi Takeshita, et al.. (2010). Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine. Journal of Infection and Chemotherapy. 17(3). 419–423. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact